The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#20 of 2,578)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 9 news outlets

twitter: 2 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 22 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 9 news stories from 9 outlets.

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

BioTech Gate, 26 Mar 2018

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Tucson News Now, 26 Mar 2018

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Benzinga, 26 Mar 2018

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Biz Wire Express, 26 Mar 2018

GlobeNewswire 2018-03-26 Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung…

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

PM 360, 26 Mar 2018

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Minyanville: Finance , 26 Mar 2018

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

NASDAQ, 26 Mar 2018

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Pettinga: Stock Market, 26 Mar 2018

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Financial Content, 26 Mar 2018

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels…

Dove Medical Press

Article Metrics

The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages

About this Attention Score

Mentioned by

Citations

Readers on

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

BioTech Gate, 26 Mar 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Tucson News Now, 26 Mar 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Benzinga, 26 Mar 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Biz Wire Express, 26 Mar 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

PM 360, 26 Mar 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Minyanville: Finance , 26 Mar 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

NASDAQ, 26 Mar 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Pettinga: Stock Market, 26 Mar 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD

Financial Content, 26 Mar 2018